Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03858270
Recruitment Status : Not yet recruiting
First Posted : February 28, 2019
Last Update Posted : February 28, 2019
Sponsor:
Information provided by (Responsible Party):
Navid Seraji-Bozorgzad, Wayne State University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : March 1, 2022
  Estimated Study Completion Date : June 1, 2023